Volume 68, Issue 4, Pages (October 2005)

Slides:

Advertisements

Similar presentations

Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study Mark Unruh, Robert Benz, Tom Greene, Guofen Yan, Srinivasan.

Advertisements

Michael Allon, Michelle L. Robbin Kidney International

Reduced renal function in patients with simple renal cysts

Volume 66, Issue 6, Pages (December 2004)

Volume 54, Issue 4, Pages (October 1998)

Volume 69, Issue 11, Pages (June 2006)

Volume 57, Issue 4, Pages (April 2000)

Volume 58, Issue 1, Pages (July 2000)

Volume 66, Issue 4, Pages (October 2004)

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Volume 57, Issue 5, Pages (May 2000)

Volume 54, Issue 2, Pages (August 1998)

Volume 68, Issue 4, Pages (October 2005)

Volume 65, Issue 6, Pages (June 2004)

Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 82, Issue 1, Pages (July 2012)

Volume 80, Issue 10, Pages (November 2011)

Volume 63, Issue 3, Pages (March 2003)

Volume 68, Issue 6, Pages (December 2005)

Volume 56, Issue 2, Pages (August 1999)

Volume 57, Issue 4, Pages (April 2000)

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Survival advantage in Asian American end-stage renal disease patients1

Volume 68, Issue 5, Pages (November 2005)

What really happens to people on long-term peritoneal dialysis?

Volume 57, Issue 6, Pages (June 2000)

Volume 77, Issue 7, Pages (April 2010)

Renal risk scores: Progress and prospects

Long-term outcomes in nondiabetic chronic kidney disease

Volume 60, Issue 1, Pages (July 2001)

Volume 62, Issue 6, Pages (December 2002)

Study of Heart and Renal Protection (SHARP)

Volume 91, Issue 3, Pages (March 2017)

U-shaped effect of eGFR and mortality

Volume 74, Issue 8, Pages (October 2008)

Body size and outcomes on peritoneal dialysis in the United States

Volume 58, Issue 1, Pages (July 2000)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 70, Issue 10, Pages (November 2006)

Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower

Alternate-day dialysis may be needed for hemodialysis patients

Volume 56, Issue 5, Pages (November 1999)

A fractional dialysate collection method to estimate solute removal in continuous venovenous hemodialysis Nigel S. Kanagasundaram, A. Brett Larive, Emil.

Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter Kidney International

Volume 76, Issue 8, Pages (October 2009)

Volume 76, Issue 9, Pages (November 2009)

Reduced renal function in patients with simple renal cysts

Volume 63, Issue 6, Pages (June 2003)

Nephrology Crossword: Glomerulonephritis

Volume 64, Issue 3, Pages (September 2003)

Volume 68, Issue 2, Pages (August 2005)

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease C.P. Kovesdy, S. Ahmadzadeh,

Volume 65, Issue 4, Pages (April 2004)

Volume 58, Issue 1, Pages (July 2000)

Volume 54, Issue 4, Pages (October 1998)

Dialysis dose and gender: A different hypothesis

Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients Finnian R. Mc Causland, Sushrut S.

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Volume 77, Issue 7, Pages (April 2010)

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

Volume 57, Issue 2, Pages (October 2000)

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 87, Issue 3, Pages (March 2015)

Volume 61, Issue 2, Pages (February 2002)

Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients M.R. Marshall, B.G. Byrne, P.G. Kerr,

Volume 58, Issue 5, Pages (November 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 66, Issue 6, Pages (December 2004)

Presentation transcript:

Volume 68, Issue 4, Pages 1766-1776 (October 2005) Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study? Johanna T. Dwyer, Brett Larive, June Leung, Michael V. Rocco, T.O.M. Greene, Jerrilynn Burrowes, Glenn M. Chertow, David B. Cockram, W. Cameron Chumlea, John Daugirdas, Anne Frydrych, John W. Kusek, the Hemo Study Group Kidney International Volume 68, Issue 4, Pages 1766-1776 (October 2005) DOI: 10.1111/j.1523-1755.2005.00593.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Serum creatinine: Relative risks (with 95% CI) for categories of baseline values adjusting for baseline demographic variables. Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Serum albumin: Relative risks (with 95% CI) for categories of baseline values adjusting for baseline demographic variables. Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Total cholesterol: Relative risks (with 95% CI) for categories of baseline values adjusting for baseline demographic variables. Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Arm circumference for men and women: Relative risks (with 95% CI) for categories of baseline values adjusting for baseline demographic variables. Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Calf circumference: Relative risks (with 95% CI) for categories of baseline values adjusting for baseline demographic variables. Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 BMI: Relative risks (with 95% CI) for categories of baseline values adjusting for baseline demographic variables. Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Subscapular skinfolds (with 95% CI) for categories of baseline values adjusting for baseline demographic variables. Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Relative risks (and 95% CIs) associated with designated increases among all values of certain baseline nutrition variables. Relative risks shown by follow-up period: first 6 months (solid circles), 6 to 18 months (circles with crosses), and subsequently (squares). Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Relative risks (and 95% CIs) associated with designated increases among lower values of certain baseline nutrition variables. Relative risks shown by follow-up period: first 6 months (solid circles), 6 to 18 months (circles with crosses), and subsequently (squares). Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 10 Relative risks (and 95% CIs) associated with designated increases among higher values of certain baseline nutrition variables. Relative risks shown by follow-up period: first 6 months (solid circles), 6 to 18 months (circles with crosses), and subsequently (squares). Kidney International 2005 68, 1766-1776DOI: (10.1111/j.1523-1755.2005.00593.x) Copyright © 2005 International Society of Nephrology Terms and Conditions